Skip to main content

AstraZeneca PLC

corporate_fare Company Profile

AstraZeneca PLC

AZN·NYSE·Life Sciences·CIK 0000901832

AstraZeneca PLC is a public limited company based in the United Kingdom. The company was formed in 1993 when the pharmaceutical, agrochemical, and specialty chemical businesses of Imperial Chemical Industries PLC were separated. Initially named Zeneca Group PLC, it changed its name to AstraZeneca PLC on April 6, 1999. In 1999, the company sold its specialty chemical business and merged with Astra of Sweden. In 2000, it separated its agrochemical business and merged it with Novartis's similar business to create Syngenta AG. The company expanded its operations in 2007 by acquiring MedImmune, a biologics and vaccines business located in the United States. In 2021, AstraZeneca further grew by acquiring Alexion, a rare disease business also based in the United States. In connection with the 1999 merger with Astra, the company's share capital was redenominated in US dollars. On April 6, 1999, Zeneca shares were cancelled and new US dollar-denominated shares were issued, credited as fully paid, on a one-for-one basis. The company also issued 50,000 Redeemable Preference Shares for cash, at par, at the same time.

AstraZeneca PLC (NYSE:AZN) is a publicly traded company in the Life Sciences sector. Wiseek monitors AZN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • US FDA Approves AstraZeneca's Imfinzi for Early Bladder Cancer, First New Therapy in 30 Years
  • FDA Extends Review Period for AstraZeneca's Breast Cancer Drug Camizestrant
  • FDA Approves AstraZeneca's Datroway for 1st-Line Metastatic Triple-Negative Breast Cancer
  • Enhertu Recommended for EU Approval in HER2-Positive Metastatic Solid Tumours
  • AstraZeneca's Camizestrant Recommended for EU Approval in 1st-Line Advanced Breast Cancer

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$58.74B
Net Income
$10.23B
Diluted EPS
$6.54
Op. Cash Flow
$14.57B
Free Cash Flow
$11.77B
Gross Profit
$48.11B
Operating Income
$13.74B
Cash & Equivalents
$1.33B
Total Debt
$24.71B
Debt / Equity
0.51×
Net Margin
17.4%
Source: 20-F · filed 2026-02-24 · accession 0001104659-26-019130

Insider Transactions

AZN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with A →
$178.75
52-week range · as of 2026-05-29 $131.03 – $212.71
Market cap
$277.22B
Volume
2.4M (1.2× avg)
3-mo avg 1.9M
Live data · 2026-06-14 02:11 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AZN - Latest Insights

AZN
May 29, 2026, 6:43 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $186.07
Real-time Price: $178.75 info
Change: -$7.32 (-4%) info
Market Cap: $277.217B info
AZN
May 27, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $187.38
Real-time Price: $178.75 info
Change: -$8.63 (-5%) info
Market Cap: $277.217B info
AZN
May 26, 2026, 7:17 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $188.46
Real-time Price: $178.75 info
Change: -$9.71 (-5%) info
Market Cap: $277.217B info
AZN
May 26, 2026, 7:09 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $188.70
Real-time Price: $178.75 info
Change: -$9.95 (-5%) info
Market Cap: $277.217B info
AZN
May 26, 2026, 7:02 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $188.68
Real-time Price: $178.75 info
Change: -$9.93 (-5%) info
Market Cap: $277.217B info
AZN
May 22, 2026, 9:40 AM EDT
Source: BayStreet
Importance Score:
7
Price at Filing: $188.35
Real-time Price: $178.75 info
Change: -$9.59 (-5%) info
Market Cap: $277.217B info
AZN
May 18, 2026, 9:42 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $183.25
Real-time Price: $178.75 info
Change: -$4.50 (-2%) info
Market Cap: $277.217B info
AZN
May 18, 2026, 9:36 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $183.16
Real-time Price: $178.75 info
Change: -$4.41 (-2%) info
Market Cap: $277.217B info
AZN
May 14, 2026, 7:25 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $187.14
Real-time Price: $178.75 info
Change: -$8.39 (-4%) info
Market Cap: $277.217B info
AZN
May 01, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $185.05
Real-time Price: $178.75 info
Change: -$6.30 (-3%) info
Market Cap: $277.217B info
AZN
May 01, 2026, 8:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $185.00
Real-time Price: $178.75 info
Change: -$6.25 (-3%) info
Market Cap: $277.217B info
AZN
Apr 29, 2026, 7:23 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $186.17
Real-time Price: $178.75 info
Change: -$7.42 (-4%) info
Market Cap: $277.217B info
AZN
Apr 28, 2026, 7:31 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $186.08
Real-time Price: $178.75 info
Change: -$7.33 (-4%) info
Market Cap: $277.217B info
AZN
Apr 27, 2026, 6:29 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $189.64
Real-time Price: $178.75 info
Change: -$10.89 (-6%) info
Market Cap: $277.217B info
AZN
Apr 21, 2026, 6:19 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $201.10
Real-time Price: $178.75 info
Change: -$22.35 (-11%) info
Market Cap: $277.217B info
AZN
Apr 20, 2026, 7:03 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $201.43
Real-time Price: $178.75 info
Change: -$22.68 (-11%) info
Market Cap: $277.217B info
AZN
Apr 02, 2026, 9:27 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $199.18
Real-time Price: $178.75 info
Change: -$20.43 (-10%) info
Market Cap: $277.217B info
AZN
Mar 31, 2026, 7:48 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $194.96
Real-time Price: $178.75 info
Change: -$16.21 (-8%) info
Market Cap: $277.217B info
AZN
Mar 27, 2026, 8:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $190.07
Real-time Price: $178.75 info
Change: -$11.32 (-6%) info
Market Cap: $277.217B info
AZN
Mar 16, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $190.59
Real-time Price: $178.75 info
Change: -$11.84 (-6%) info
Market Cap: $277.217B info